Zynerba Pharmaceuticals to Participate in Upcoming Investor Conferences
Nov 09, 2016 12:00 pm UTC| Business
DEVON, Pa., Nov. 09, 2016 -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today...
Nov 09, 2016 12:00 pm UTC| Business
Phase 3 Program of Zuprata™ for Macular Edema Associated with Retinal Vein Occlusion to be Initiated in the First Half of 2017 Phase 1/2 Trial for Diabetic Macular Edema to be Initiated by the End of 2016 ALPHARETTA,...
Troy University Renews Student Services Support Partnership with Greenwood Hall
Nov 09, 2016 12:00 pm UTC| Business
SANTA MONICA, Calif., Nov. 09, 2016 -- Greenwood Hall, Inc. (OTCQB:ELRN), a Los Angeles-based education technology company that helps colleges and universities improve student engagement and outcomes, announced today...
Intra-Cellular Therapies Reports Third Quarter 2016 Financial Results and Provides Corporate Update
Nov 09, 2016 12:00 pm UTC| Business
NEW YORK, Nov. 09, 2016 -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced its financial...
Nov 09, 2016 12:00 pm UTC| Business
UTRECHT, The Netherlands and EDINBURGH, UK, Nov. 09, 2016 -- Merus N.V. (NASDAQ:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, announced today that it has been...
NewLink Genetics to Participate in Three Investor Conferences in November
Nov 09, 2016 12:00 pm UTC| Business
AMES, Iowa, Nov. 09, 2016 -- NewLink Genetics Corporation (NASDAQ:NLNK), a biopharmaceutical company focused on bringing novel immuno-oncology therapies to patients with cancer, today announced that it will participate...
Recro Pharma to Present at Upcoming Investor Conferences
Nov 09, 2016 12:00 pm UTC| Business
MALVERN, Pa., Nov. 09, 2016 -- Recro Pharma, Inc. (“Recro” or the “Company”) (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on products for hospital and ambulatory care settings, currently...